DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Gastrografin (Diatrizoate Meglumine / Diatrizoate Sodium) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

GASTROGRAFIN SUMMARY

Gastrografin (Diatrizoate Meglumine and Diatrizoate Sodium Solution) is a palatable lemon-flavored water-soluble iodinated radiopaque contrast medium for oral or rectal administration only. Each mL contains 660 mg diatrizoate meglumine and 100 mg diatrizoate sodium; pH has been adjusted to 6.0 to 7.6 with sodium hydroxide. Each mL contains approximately 4.8 mg (0.21 mEq) sodium and 367 mg organically bound iodine.

Gastrografin (Diatrizoate Meglumine and Diatrizoate Sodium Solution) is indicated for radiographic examination of segments of the gastrointestinal tract (esophagus, stomach, proximal small intestine, and colon). The preparation is particularly indicated when a more viscous agent such as barium sulfate, which is not water-soluble, is not feasible or is potentially dangerous.

Gastrografin may also be used as an adjunct to contrast enhancement in computed tomography of the torso (body imaging); the preparation is indicated, in conjunction with intravenous administration of a radiopaque contrast agent, when unenhanced imaging may not provide sufficient definition in distinguishing normal loops of bowel from adjacent organs or areas of suspected pathology.


See all Gastrografin indications & dosage >>

GASTROGRAFIN NEWS HIGHLIGHTS

Media Articles Related to Gastrografin (Diatrizoate Meglumine / Diatrizoate Sodium)

VIDA Diagnostics Gains FDA Approval For Comprehensive Lung Analysis Software
Source: Respiratory / Asthma News From Medical News Today [2008.11.29]

German Innovation For HIV/AIDS Diagnostics Has Been Used 2.5 Million Times In 2008
Source: HIV / AIDS News From Medical News Today [2008.11.29]

Prenatal Diagnostic Technology Allows Diagnosis Of Inherited Diseases Such As Cystic Fibrosis Caused By Single Gene Mutations
Source: Blood / Hematology News From Medical News Today [2008.11.25]

Cepheid Receives Health Canada License For First Molecular Diagnostic Test For MRSA And S. Aureus Soft Tissue Infections
Source: MRSA / Drug Resistance News From Medical News Today [2008.11.25]

Prediagnostic BMI, Plasma C-Peptide Concentration, And Prostate Cancer-Specific Mortality In Men With Prostate Cancer: A Long-Term Survival Analysis
Source: Prostate / Prostate Cancer News From Medical News Today [2008.11.24]

more >>

Published Studies Related to Gastrografin (Diatrizoate Meglumine / Diatrizoate Sodium)

Water-soluble contrast medium (gastrografin) value in adhesive small intestine obstruction (ASIO): a prospective, randomized, controlled, clinical trial. [2008.10]

Water-Soluble Contrast Medium (Gastrografin) Value in Adhesive Small Intestine Obstruction (Asio): A Prospective, Randomized, Controlled, Clinical Trial. [2008.08.08]

Randomized controlled trial of Gastrografin in adhesive small bowel obstruction. [2005.08]

The effect of in-vivo intravenous administration of sodium meglumine diatrizoate on some haematological parameters. [2007.10]

[Gastrografin challenge test for the management of subileus in children] [2007]

more >>

Clinical Trials Related to Gastrografin (Diatrizoate Meglumine / Diatrizoate Sodium)

(Gastrografin Use in Small Bowel Obstruction Caused by Adherences) [Completed]

Value of CT-Scan and Oral Gastrografin in the Management of Post Operative Small Bowel Obstruction [Recruiting]

Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT [Recruiting]

Safety Study of Autologous Stem Cell in Liver Cirrhosis [Terminated]

Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells by Mini-Thoracotomy [Completed]

more >>

Page last updated: 2008-11-29

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008